trial

Effects of Oxytocin on Negative Symptoms and Social Cognition in Schizophrenia and Its Possible Mechanisms

NCTId NCT03662425
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 43 (actual)
Sponsored by Shanghai Mental Health Center
Primary completion 2020-03-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
43 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2018-07-21
Primary completion
2020-03-31
Eligibility
MALE · 18 Years · 55 Years

Interventions & indications

Drugs
Oxytocin

Sponsors

Shanghai Mental Health CenterLead Sponsor
Chinese Academy of SciencesCollaborator

Investigators

1
Zhenghui Yi, Ph.DPrincipal Investigator

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
43
Phase
NA
Primary Completion Date
2020-03-31
Status
COMPLETED
relationships
The graph out of here
drug
Oxytocin
drug
lead_sponsor
Shanghai Mental Health Center
company
collaborator
Chinese Academy of Sciences
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Zhenghui Yi, Ph.D
person